Home / Products / Pharma / General / By Brand Name / Montex
Montelukast Sodium BP
Montex (Montelukast sodium) is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT1 receptor.
Montex 4 chewable tablet: Each chewable tablet contains Montelukast Sodium BP equivalent to 4 mg Montelukast. Montex 5 chewable tablet: Each chewable tablet contains Montelukast Sodium BP equivalent to 5 mg Montelukast. Montex 10 tablet: Each film coated tablet contains Montelukast Sodium BP equivalent to 10 mg Montelukast.
Indications And Uses
Montex is indicated for the prophylaxis and chronic treatment of asthma in adults and children.
Dosage And Administration
Adults 15 years of age: One tablet (10mg) once daily at bed time. Children 6-14 years of age: One chewable tablet (5mg) once daily at bed time. Children 2-6 years of age: One chewable tablet (4mg) once daily at bed time. Montex may be taken with or without food or as directed by physician. Safety and effectiveness in children younger than 2 years of age have not been established.
Motelukast has been generally well tolerated. Side effects, which usually are mild, including gastro-intestinal disturbances, dry mouth, thirst; hypersensitivity reactions including anaphylaxis, angioedema and skin reactions; asthenia, dizziness, irritability, restlessness, headache, sleep disorders (insomnia, drowsiness, nightmares); upper respiratory tract infection, fever, arthralgia, myalgia. The overall incidence of side effects reported with montelukast was comparable to placebo.
Montelukast is not indicated for use in acute asthma attacks. Therapy with Montelukast can be continued during acute exacerbation of asthma. Montelukast should not be used as monotherapy for the treatment and management of exercise induced bronchospasm. There are no adequate and well controlled studies in pregnant women. Montekulast should be used during only if clearly needed. Montelukast is excreted in milk. So caution should be exercised when Montelukast is given to a nursing mother.
It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers, such as phenobaebital or rifampin, are co-administered with montelukast.
Montelukast is contraindicated in patients who are Hypersensitive to any component of this product.
Montex 4 chewable tablet: Each box contains 3x10 tablets in blister pack. Montex 5 chewable tablet: Each box contains 2x10 tablets in blister pack. Montex 10 tablet: Each box contains 2x10 tablets in blister pack.